Abbott India Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Abbott India ha un patrimonio netto totale di ₹35.2B e un debito totale di ₹0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente ₹50.6B e ₹15.4B. L'EBIT di Abbott India è ₹14.7B rendendo il suo rapporto di copertura degli interessi -6.8. Ha liquidità e investimenti a breve termine pari a ₹11.1B.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
₹0
Debito
| Indice di copertura degli interessi | -6.8x |
| Contanti | ₹11.06b |
| Patrimonio netto | ₹35.21b |
| Totale passività | ₹15.42b |
| Totale attività | ₹50.63b |
Aggiornamenti recenti sulla salute finanziaria
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Recent updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year
May 12Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( ₹31.1B ) di ABBOTINDIA superano le sue passività a breve termine ( ₹13.8B ).
Passività a lungo termine: Le attività a breve termine di ABBOTINDIA ( ₹31.1B ) superano le sue passività a lungo termine ( ₹1.6B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: ABBOTINDIA è esente da debiti.
Riduzione del debito: ABBOTINDIA non aveva debiti 5 anni fa.
Copertura del debito: ABBOTINDIA non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.
Copertura degli interessi: ABBOTINDIA non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.